These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 27121713)

  • 1. Development of Amino Acid-Based Radiopharmaceuticals for Tumor Imaging.
    Zhu J; Song X; Zhang J
    Mini Rev Med Chem; 2018; 18(7):561-583. PubMed ID: 27121713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-natural amino acids for tumor imaging using positron emission tomography and single photon emission computed tomography.
    McConathy J; Goodman MM
    Cancer Metastasis Rev; 2008 Dec; 27(4):555-73. PubMed ID: 18648909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiohalogenated nonnatural amino acids as PET and SPECT tumor imaging agents.
    McConathy J; Yu W; Jarkas N; Seo W; Schuster DM; Goodman MM
    Med Res Rev; 2012 Jul; 32(4):868-905. PubMed ID: 21793016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiolabeled amino acids for tumor imaging with PET: radiosynthesis and biological evaluation of 2-amino-3-[18F]fluoro-2-methylpropanoic acid and 3-[18F]fluoro-2-methyl-2-(methylamino)propanoic acid.
    McConathy J; Martarello L; Malveaux EJ; Camp VM; Simpson NE; Simpson CP; Bowers GD; Olson JJ; Goodman MM
    J Med Chem; 2002 May; 45(11):2240-9. PubMed ID: 12014962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiolabeled Sugars Used for PET and SPECT Imaging.
    Barrios-Lopez B; Bergstrom K
    Curr Radiopharm; 2016; 9(3):180-186. PubMed ID: 26004636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological properties of radiohalogenated α,α-disubstituted amino acids for PET and SPECT imaging of amino acid transporters (AATs).
    Goodman MM; Yu W; Jarkas N
    J Labelled Comp Radiopharm; 2018 Mar; 61(3):272-290. PubMed ID: 29143354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiolabeled glucose derivatives for tumor imaging using SPECT and PET.
    Liu T; Zhang J; Wang X; Yang J; Tang Z; Lu J
    Curr Med Chem; 2014; 21(1):24-34. PubMed ID: 23992343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (18)F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization.
    Vallabhajosula S
    Semin Nucl Med; 2007 Nov; 37(6):400-19. PubMed ID: 17920348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural modifications of amino acid sequences of radiolabeled peptides for targeted tumor imaging.
    Maleki F; Farahani AM; Rezazedeh F; Sadeghzadeh N
    Bioorg Chem; 2020 Jun; 99():103802. PubMed ID: 32330735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging gliomas with positron emission tomography and single-photon emission computed tomography.
    Bénard F; Romsa J; Hustinx R
    Semin Nucl Med; 2003 Apr; 33(2):148-62. PubMed ID: 12756647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiolabeled amino acids for oncologic imaging.
    Huang C; McConathy J
    J Nucl Med; 2013 Jul; 54(7):1007-10. PubMed ID: 23708197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amino Acid transporter-targeted radiotracers for molecular imaging in oncology.
    Kong FL; Yang DJ
    Curr Med Chem; 2012; 19(20):3271-81. PubMed ID: 22664245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and evaluation of an
    Čolović M; Rousseau E; Zhang Z; Lau J; Zhang C; Kuo HT; Yang H; Schaffer P; François Bénard ; Lin KS
    Bioorg Med Chem Lett; 2018 Dec; 28(22):3579-3584. PubMed ID: 30316632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical applications of positron emission tomography-computed tomography in oncology.
    Kumar R; Halanaik D; Malhotra A
    Indian J Cancer; 2010; 47(2):100-19. PubMed ID: 20448371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of ¹⁸F-labeled fluoropropyl tryptophan analogs as potential PET probes for tumor imaging.
    Chiotellis A; Mu L; Müller A; Selivanova SV; Keller C; Schibli R; Krämer SD; Ametamey SM
    Eur J Med Chem; 2013; 70():768-80. PubMed ID: 24239624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of α-Methyl versus α-Hydrogen Substitution on Brain Availability and Tumor Imaging Properties of Heptanoic [F-18]Fluoroalkyl Amino Acids for Positron Emission Tomography (PET).
    Bouhlel A; Alyami W; Li A; Yuan L; Rich K; McConathy J
    J Med Chem; 2016 Apr; 59(7):3515-31. PubMed ID: 26967318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular tracers for the PET and SPECT imaging of disease.
    Pimlott SL; Sutherland A
    Chem Soc Rev; 2011 Jan; 40(1):149-62. PubMed ID: 20818455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear medicine imaging in tuberculosis using commercially available radiopharmaceuticals.
    Sathekge M; Maes A; D'Asseler Y; Vorster M; Van de Wiele C
    Nucl Med Commun; 2012 Jun; 33(6):581-90. PubMed ID: 22422098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bispecific antibody pretargeting of radionuclides for immuno single-photon emission computed tomography and immuno positron emission tomography molecular imaging: an update.
    Sharkey RM; Karacay H; McBride WJ; Rossi EA; Chang CH; Goldenberg DM
    Clin Cancer Res; 2007 Sep; 13(18 Pt 2):5577s-5585s. PubMed ID: 17875792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New tracers beyond FDG in head and neck oncology.
    Gornik G; Weber W
    Q J Nucl Med Mol Imaging; 2011 Oct; 55(5):529-40. PubMed ID: 22019710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.